Secondary Logo

Journal Logo

May 2020 - Volume 43 - Issue 4
pp: 107-152

Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib

Qin, Jim S.; Johnstone, Timothy G.; Baturevych, Alex; More

Journal of Immunotherapy. 43(4):107-120, May 2020.

Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy

Oyama, Yasuhiro; Onishi, Hideya; Koga, Satoko; More

Journal of Immunotherapy. 43(4):121-133, May 2020.


Pembrolizumab Treatment and Pathologic Therapeutic Evaluation for Granulocyte Colony-stimulating Factor-producing Bladder Cancer: A Case Report and Literature Review

Muramatsu-Maekawa, Yuka; Taniguchi, Tomoki; Ito, Hiroki; More

Journal of Immunotherapy. 43(4):134-138, May 2020.